by Tyler Durden
On Thursday, Japan’s Ministry of Health announced that about 1.6 million doses of the Moderna Covid-19 vaccine have been discontinued. Due to the contamination in some of the flasks that interact with the magnet, According to a ministry official.
Many vaccination centers reported finding it foreign matter in doses.
“It is a material that interacts with magnetssaid the official Nikkiadding, “It can be metal.“
Meanwhile, Moderna confirmed receiving “several complaints of particulate matter” in vials distributed in Japan, but that “no safety or efficacy issues” were found related to the reports.
“The company investigates the reports and remains committed to working transparently and promptly with its partner Takeda and regulators to address any potential concerns,” a company spokesperson said. Nikki, adding that the reason behind this was a “manufacturing case” at a factory in Spain.
After complaints were made, the vaccine batch in question as well as two adjacent lots were withdrawn from circulation “out of great caution,” according to the spokesperson.
Prime Minister Yoshihide Suga told reporters Thursday afternoon that he had instructed the ministry to look into the issue with safety as a top priority, adding that he had received reports that the withdrawal “will not have a significant impact on the country’s vaccination campaign.” –Nikki
The strange substance that ‘interacts with magnets’ is sure to revive speculation about the viral ‘Covid-19 vaccine magnet challenge’, with dozens of people taping magnets to their vaccine injection sites.
And while many “fact-checking” sites have taken a gander at what’s going on, the two most common explanations are that she “faked” or “her skin was a little wet.”
Critics have noted the fact that graphene oxide is not included as an ingredient in any available Covid-19 vaccine, while skeptics oppose the “so what?” If random batches are contaminated with foreign substances, on purpose or on purpose, they will of course not be included in the ingredients.
Anyway, Moderna’s stock isn’t too happy today: